Longduoduo Co

Longduoduo Co P/B

The P/B (Price-to-Book Ratio) of Longduoduo Co (LDDD) as of Nov 3, 2026 is 21.76. In the previous year, P/B (Price-to-Book Ratio) was 12.92 — a change of 68.34% (higher).

P/B

21.76

YoY

68.34%

Last updated:

P/B (Price-to-Book Ratio) of Longduoduo Co is 2026 21.76 . P/B (Price-to-Book Ratio) of Longduoduo Co was 2025 12.92 . It decreases by 68.34% higher compared to the previous year.

The Longduoduo Co P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2020
21,871.43 USD
Jan 1, 2021
-45.81 USD
Jan 1, 2022
-16.48 USD
Jan 1, 2023
-28.25 USD
Jan 1, 2024
21.79 USD
Jan 1, 2025
12.92 USD
Jan 1, 2026
21.76 USD
The Longduoduo Co P/B history
YEARP/BYoY
21.76+68.34%
12.92-40.69%
21.79-177.15%
-28.25+71.38%
-16.48-64.02%
-45.81-100.21%
21,871.43—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Longduoduo Co Stock analysis

What does Longduoduo Co do? Longduoduo Co Ltd operates in the Health Care Providers & Services industry, focusing on preventive care for cardiovascular and cerebrovascular diseases such as myocardial infarction and cerebral infarction. The company collaborates with third-party healthcare service providers to offer preventive healthcare solutions, including health products and medical examinations. Its primary market is domestic, serving customers seeking preventive services for conditions like hemiplegia and cardiovascular diseases. The firm's revenue comes from providing these integrated preventive care services through its partnerships and domestic operations. Longduoduo Co Ltd generates income by delivering preventive healthcare solutions that combine health products with medical examinations and services. The company partners with third-party healthcare service providers to expand its service offerings, targeting individuals concerned about cardiovascular and cerebrovascular health risks. Domestic customers purchase these preventive care packages, which address specific health issues including myocardial infarction prevention and hemiplegia management. The business model relies on domestic market sales of these integrated health solutions. The company's revenue streams are derived from domestic sales of preventive healthcare services, including health products and medical examinations provided through third-party partnerships. Longduoduo focuses on cardiovascular and cerebrovascular disease prevention, targeting customers interested in avoiding conditions like myocardial infarction and cerebral infarction. Its services are designed to address specific health concerns such as hemiplegia, with the firm operating exclusively within the domestic market to deliver these preventive care solutions. Longduoduo Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Longduoduo Co stock

P/B (Price-to-Book Ratio) of Longduoduo Co is 21.76 in 2026.

P/B (Price-to-Book Ratio) of Longduoduo Co changed from 12.92 to 21.76, representing a 68.34% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Longduoduo Co since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Longduoduo Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Longduoduo Co

All Key Metrics — Longduoduo Co